Evaluation of bla OXA-48-like point mutation carbapenemase-producing Enterobacterales in Prapokklao Hospital, Thailand
Microbiology Spectrum · 05.12.2024 · 12 (12)
DOI: 10.1128/spectrum.00198-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 05.12.2024. Verfasst von Sirijan Santajit und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si, Thammarat, Thailand. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Point Mutation, Enterobacteriaceae Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand (NRCT).
Abstract (Originalsprache)
Carbapenemase-producing Enterobacterales (CPE) isolates increasingly carry oxacillinase-48 (OXA-48)-like enzymes encoded by bla OXA-48-like , which can confer high levels of carbapenem resistance. This aims to determine the prevalence of CPE and genetic variation among bla OXA-48-like -carrying isolates recovered from Prapokklao Hospital in Chanthaburi Province, Thailand in 2016–2017. In total, 122 carbapenem-resistant Enterobacterales (CRE) isolates were recovered from clinical samples. CRE were evaluated using standard biochemical tests and MIC test strips. Carbapenemase production was assessed through the modified Hodge test (MHT), modified carbapenem inactivation method (mCIM), and EDTA-modified carbapenem inactivation method (eCIM). Detection of bla OXA-48-like mutations was conducted via PCR and confirmed by Sanger sequencing. Among these CRE isolates, 72 (59.02%), 44 (36.07%), 3 (2.46%), and 3 (2.46%) were Klebsiella pneumoniae , Escherichia coli , Enterobacter aerogenes , and Enterobacter cloacae , respectively. The MHT identified carbapenemase production in 108 isolates (88.52%). Based on the mCIM, 81 isolates (66.39%) were carbapenemase producers. Seventy-three isolates (59.84%) were eCIM-positive, indicating metallo-β-lactamase production. Three distinct genetic variants of the bla OXA-48-like gene were identified among the isolates, including the wild-type and two point mutation types harboring the mutations E168Q and S171A (mutation type 1) and E168Q, S171A, and R214S (mutation type 2). Multiple-sequence alignment and in silico analysis revealed variation of R214 located in the β5–β6 loop. This study identified bla OXA-48-like point mutation groups and carbapenemase production, predominantly metallo-β-lactamases, among CRE isolates, especially K. pneumoniae and E. coli . These findings highlight the importance of implementing stringent infection control measures and active antimicrobial resistance surveillance to combat the spread of difficult-to-treat, metallo-β-lactamase-producing CRE in healthcare settings. IMPORTANCE In this study, we aimed to investigate genetic variation and CPE among bla OXA-48-like carrying isolates recovered from Prapokklao Hospital, Chanthaburi Province, Thailand, during 2016–2017. A total of 122 carbapenem-resistant Enterobacterales (CRE) were recovered from clinical samples in Prapokklao Hospital. All CRE samples were confirmed by standard biochemical tests and minimum inhibitory concentration (MIC) test strips (E-test). The carbapenemase production was determined using the modified Hodge test (MHT), the modified carbapenem inactivation method (mCIM), and EDTA-CIM (eCIM). Three single mutations (E168Q, S171A, and R214S) were characterized in this study. This mutation might reflect the hydrolysis of the modified β-lactam spectrum, especially carbapenem, by OXA-48-like. Our report provides evidence of the bla OXA-48-like point mutation and carbapenemase-producing phenotype of CRE detected in this healthcare setting. Effective control measures and active surveillance of drug resistance in nosocomial pathogens are crucial for controlling diseases associated with difficult-to-treat bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si, Thammarat, Thailand.
- Research Center in Tropical Pathobiology, Walailak University, Nakhon Si, Thammarat, Thailand.
- Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
- Department of Microbiology, Prapokklao Hospital, Chanthaburi, Thailand.
- Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
- Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
ORCID-Profile: Sirijan Santajit, Nitaya Indrawattana
Förderung
- National Research Council of Thailand (NRCT)
Zitieren
APA
Santajit, S., Tunyong, W., Kong-Ngoen, T., Arsheewa, W., Hinthong, W., Pumirat, P., Sookrung, N., & Indrawattana, N. (2024). Evaluation of bla OXA-48-like point mutation carbapenemase-producing Enterobacterales in Prapokklao Hospital, Thailand. Microbiology Spectrum, 12(12). https://doi.org/10.1128/spectrum.00198-24
Vancouver
Santajit S, Tunyong W, Kong-Ngoen T, Arsheewa W, Hinthong W, Pumirat P, et al. Evaluation of bla OXA-48-like point mutation carbapenemase-producing Enterobacterales in Prapokklao Hospital, Thailand. Microbiology Spectrum. 2024;12(12). doi:10.1128/spectrum.00198-24
BibTeX
@article{Santajit2024,
author = {Santajit, Sirijan and Tunyong, Witawat and Kong-Ngoen, Thida and Arsheewa, Weewan and Hinthong, Woranich and Pumirat, Pornpan and Sookrung, Nitat and Indrawattana, Nitaya},
title = {Evaluation of bla OXA-48-like point mutation carbapenemase-producing Enterobacterales in Prapokklao Hospital, Thailand},
journal = {Microbiology Spectrum},
year = {2024},
volume = {12},
number = {12},
doi = {10.1128/spectrum.00198-24}
}
EUVIMED